Search Results - "Kratter, Ian H."

Refine Results
  1. 1
  2. 2
  3. 3

    Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial by Batail, Jean-Marie, Xiao, Xiaoqian, Azeez, Azeezat, Tischler, Claudia, Kratter, Ian H., Bishop, James H., Saggar, Manish, Williams, Nolan R.

    Published in Translational psychiatry (03-07-2023)
    “…Here, we investigated the brain functional connectivity (FC) changes following a novel accelerated theta burst stimulation protocol known as Stanford…”
    Get full text
    Journal Article
  4. 4

    Serine 421 regulates mutant huntingtin toxicity and clearance in mice by Kratter, Ian H, Zahed, Hengameh, Lau, Alice, Tsvetkov, Andrey S, Daub, Aaron C, Weiberth, Kurt F, Gu, Xiaofeng, Saudou, Frédéric, Humbert, Sandrine, Yang, X William, Osmand, Alex, Steffan, Joan S, Masliah, Eliezer, Finkbeiner, Steven

    Published in The Journal of clinical investigation (01-09-2016)
    “…Huntington's disease (HD) is a progressive, adult-onset neurodegenerative disease caused by a polyglutamine (polyQ) expansion in the N-terminal region of the…”
    Get full text
    Journal Article
  5. 5

    Depression history modulates effects of subthalamic nucleus topography on neuropsychological outcomes of deep brain stimulation for Parkinson’s disease by Kratter, Ian H., Jorge, Ahmed, Feyder, Michael T., Whiteman, Ashley C., Chang, Yue-fang, Henry, Luke C., Karp, Jordan F., Richardson, R. Mark

    Published in Translational psychiatry (27-05-2022)
    “…Patients with psychiatric symptoms, such as depression, anxiety, and visual hallucinations, may be at increased risk for adverse effects following deep brain…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Early differences in lassitude predicts outcomes in Stanford Neuromodulation Therapy for difficult to treat depression by Benrimoh, David, Azeez, Azeezat, Batail, Jean-Marie, Xiao, Xiaoqian, Buchanan, Derrick, Bandeira, Igor D., Geoly, Andrew, Keynan, Yaakov, Kratter, Ian H., Williams, Nolan R.

    Published in Npj mental health research (28-10-2024)
    “…Stanford Neuromodulation Therapy (SNT), has recently shown rapid efficacy in difficult to treat (DTT) depression. We conducted an exploratory analysis of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression by Mitra, Anish, Raichle, Marcus E, Geoly, Andrew D, Kratter, Ian H, Williams, Nolan R

    “…Major depressive disorder (MDD) is widely hypothesized to result from disordered communication across brain-wide networks. Yet, prior resting-state-functional…”
    Get full text
    Journal Article
  10. 10

    Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment by Geoly, Andrew D, Kratter, Ian H, Toosi, Pouya, Cole, Eleanor J, Sahlem, Gregory L, Williams, Nolan R

    Published in The American journal of psychiatry (01-01-2024)
    “…Geoly previously reported that a novel, accelerated TMS paradigm known as Stanford Neuromodulation Therapy (SNT) is safe and highly effective in…”
    Get full text
    Journal Article
  11. 11

    Can (or Should) We Treat Depression and Anxiety in Parkinson's Disease Algorithmically? by Martyna, Michael R., Trapp, Nicholas T., Kratter, Ian H.

    “…Martyna et al discuss whether depression and anxiety can be treted in Parkinson's disease algorithmically. Pontone and Mills have authored a well-written and…”
    Get full text
    Journal Article
  12. 12

    Anterior Sensorimotor Subthalamic Nucleus Stimulation Is Associated With Improved Voice Function by Jorge, Ahmed, Dastolfo-Hromack, Christina, Lipski, Witold J, Kratter, Ian H, Smith, Libby J, Gartner-Schmidt, Jackie L, Richardson, R Mark

    Published in Neurosurgery (01-10-2020)
    “…Abstract Background Despite the impact of Parkinson disease (PD) on speech communication, there is no consensus regarding the effect of lead location on…”
    Get full text
    Journal Article
  13. 13

    Lateralized Effect of Thalamic Deep Brain Stimulation Location on Verbal Abstraction by Wang, Dengyu, Jorge, Ahmed, Lipski, Witold J., Kratter, Ian H., Henry, Luke C., Richardson, R. Mark

    Published in Movement disorders (01-08-2021)
    “…ABSTRACT Background Regionalized thalamic activity has been implicated in language function, and yet the effect of thalamic deep brain stimulation (DBS) on…”
    Get full text
    Journal Article
  14. 14
  15. 15

    PolyQ Disease: Too Many Qs, Too Much Function? by Kratter, Ian H., Finkbeiner, Steven

    Published in Neuron (Cambridge, Mass.) (23-09-2010)
    “…The nature of the gain-of-function toxicity found in polyglutamine (polyQ) diseases has been the subject of considerable debate. In this issue of Neuron,…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Association of Preoperative Visual Hallucinations With Cognitive Decline After Deep Brain Stimulation for Parkinson’s Disease by Kratter, Ian H, Karp, Jordan F, Chang, Yue-Fang, Whiteman, Ashley C, Feyder, Michael T, Jorge, Ahmed, Richardson, R. Mark, Henry, Luke C

    “…Objective: Deep brain stimulation (DBS) is effective for the motor symptoms of Parkinson’s disease (PD). Although most patients benefit with minimal cognitive…”
    Get full text
    Journal Article
  19. 19
  20. 20